Search results
Showing 6931 to 6945 of 8905 results
Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)
We have moved medical technologies guidance 6 to become HealthTech guidance 268. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)
We have moved Medical technologies guidance 58 to become HealthTech guidance 578. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 62 to become HealthTech guidance 602. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 60 to become HealthTech guidance 594. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 64 to become HealthTech guidance 606. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
The MAGEC system for spinal lengthening in children with scoliosis (MTG18)
August 2024: Following the lifting on the UK suspension of MAGEC system (modified MAGEC X system), NICE's prioritisation board will be reviewing the guidance that was withdrawn in April 2020. We will update this page once a decision is made.
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)
We have moved Medical technologies guidance 22 to become HealthTech guidance 362. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 21 to become HealthTech guidance 356. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Tegaderm CHG securement dressing for vascular access sites in critically ill adults (MTG25)
We have moved Medical technologies guidance 25 to become HealthTech guidance 379. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 24 to become HealthTech guidance 368. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
The TURis system for transurethral resection of the prostate (MTG23)
This guidance has been updated and replaced by NICE healthtech guidance 563.
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)
This guidance has been updated and replaced by NICE healthtech guidance 578.
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease (MTG28)
We have moved Medical technologies guidance 28 to become HealthTech guidance 405. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
GreenLight XPS for treating benign prostatic hyperplasia (MTG29)
This guidance has been updated and replaced by NICE healthtech guidance 650.
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.